Anaphylactoid reaction to ciprofloxacin

Annals of Pharmacotherapy

Volumn 37, Issue 7-8, 2003, Pages 1018-1023

  Ho, Dora Y ^a   Song, Jessica C ^b   Wang, Clifford C ^a,c  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylactoid reaction; Anaphylaxis; Bioterrorist; Ciprofloxacin; Fluoroquinolones

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANURIA; ARTICLE; CASE REPORT; CONVALESCENCE; CYANOSIS; DELIRIUM; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHONIA; EPIGASTRIC PAIN; ERYTHRODERMA; FACE EDEMA; FATALITY; FEVER; HEADACHE; HOT FLUSH; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL; PRURITUS; RASH; STRIDOR; TACHYCARDIA; TACHYPNEA; URTICARIA; VOMITING; WHEEZING;

EID: 0038779695     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C498     Document Type: Article

References (25)

1. Hooper DC. Quinolones. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:404-23.
2. Bertino J, Fish D. The safety profile of the fluoroquinolones. Clin Ther 2000;22:798-817.
3. Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J, et al. A critical review of the fluoroquinolones: focus on respiratory tract infections. Drugs 2002;62:13-59.
4. Peters B, Pinching AJ. Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex (letter). BMJ 1989;298:605.
5. Wurtz RM, Abrams D, Becker S, Jacobson MA, Mass MM, Marks SH. Anaphylactoid drug reactions to ciprofloxacin and rifampin in HIV-infected patients. Lancet 1989;1:955-6.
6. Davis H, McGoodwin E, Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989;111:1041-3.
7. Kennedy CA, Goetz MB, Mathisen GE. Ciprofloxicin-induced anaphylactoid reactions in patients infected with the human immunodeficiency virus. West J Med 1990;153:563-4.
8. Miller MS, Gaido F, Rourk MH, Spock A. Anaphylactoid reactions to ciprofloxacin in cystic fibrosis patients. Pediatr Infect Dis J 1991;10:164-5.
9. Berger TG, Franklin N. Anaphylactoid reaction to ciprofloxacin in a patient infected with the human immunodeficiency virus. J Am Academy Dermatol 1992;26:256-7.
10. Deamer RL, Prichard JG, Loman GJ. Hypersensitivity and anaphylactoid reactions to ciprofloxacin. Ann Pharmacother 1992;26:1081-4.
11. Soetikno RM, Johnson JL, Carey JT. Ciprofloxacin-induced anaphylactoid reaction in a patient with AIDS (letter). Ann Pharmacother 1993;27:1404.
12. Assouad M, Willcourt RJ, Goodman PH. Anaphylactoid reactions to ciprofloxacin. Ann Intern Med 1995;122:396-7.
13. Salon EJ, Newbrough MA, Albarracin CA, Hernandez JE. Anaphylactoid reaction to ciprofloxacin versus toxic shock syndrome (letter). Ann Pharmacother 1997;31:119-20.
14. Clutterbuck DJ, McMillan A. Anaphylactoid reaction to ciprofloxacin. Int J STD AIDS 1997;8:707-8.
15. Erdem G, Staat MA, Connelly BL, Assa'ad A. Anaphylactoid reaction to ciprofloxacin in a toddler: successful desensitization. Pediatr Infect Dis J 1999;18:563-4.
16. Davila I, Diez ML, Quirce S, Fraj J, De La Hoz B, Lazaro M. Cross-reactivity between quinolones: report of three cases. Allergy 1993;48:388-90.
17. al-Hedaithy MA, Noreddin AM. Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS. Ann Pharmacother 1996;30:612-4.
18. Smythe MA, Cappelletty DM. Anaphylactoid reaction to levofloxacin. Pharmacotherapy 2000;20:1520-3.
19. Aleman AM, Quirce S, Cuesta J, Novalbos A, Sastre J. Anaphylactoid reaction caused by moxifloxacin. J Invest Allergol Clin Immunol 2002;12:67-8.
20. Pirmohamed M, Park BK. HIV and drug allergy. Curr Opin Allergy Clin Immunol 2001:1:311-6.
21. Blanche P, Bachmeyer C, Burvy C, Sicard D. Hyperimmunoglobulinemia E syndrome in HIV infection. J Am Acad Dermatol 1997;36:106-7.
22. Natsch S, Vinks MHAM, Voogt AK, Mees EB, Meyboom RHB. Anaphylactic reactions to proton-pump inhibitors. Ann Pharmacother 2000;34:474-6. DOI 10.1345/aph.19235
23. Aspirin. In: Hebel SK, ed. Drug facts and comparisons 2002. St. Louis, MO: Facts and Comparisons, 2002:825.
24. Navas E. Problems associated with potential massive use of antimicrobial agents of prophylaxis or therapy of a bioterrorist attack. Clin Microbiol Infect 2002;8:534-9.
25. Update: adverse events associated with anthrax prophylaxis among postal employees - New Jersey. New York City, and the District of Columbia Metropolitan Area, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1051-4.